US Patent Issued to Biopharmaceutical, Albert Einstein College of Medicine, Adimab on Jan. 28 for "Monoclonal antibodies and cocktails for treatment of Ebola infections" (California, New Hampshire, Vermont, New York Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,117, issued on Jan. 28, was assigned to Biopharmaceutical Inc. (San Diego), Albert Einstein College of Medicine (Bronx, N.Y.) and Adimab LLC (Lebanon, N.H.).

"Monoclonal antibodies and cocktails for treatment of Ebola infections" was invented by Zachary A. Bornholdt (Encinitas, Calif.), Larry Zeitlin (San Diego), Kartik Chandran (Brooklyn, N.Y.), Anna Wec (Lebanon, N.H.) and Laura Walker (Norwich, Vt.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compositions and methods for the prevention and treatment of ebolavirus infection. In certain embodiments of the present invention, monoclonal antibodies substantially similar to those...